Oliver G. Inseal

Oliver G. Inseal is an R&D mechanical engineer at Pall Corporation Life Sciences Department


Filtration Designs Remove Processing Bottlenecks for High-Yield Biotech Drugs

Biotech companies are running into production bottlenecks because standard purification and separation technologies lack the capability to remove the elevated levels of biomass from high titer solutions. Recent developments in filter technology offer the biotech industry a cost-effective solution to processing challenges by reducing bottlenecks, thereby accelerating the time-to-market of new drugs.